Clinical Trial Update: Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of dexmedetomidine on brain homeostasis and neurocognitive outcomes in patients with brain tumors and related metabolic, infl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Hypoxic Brain Injury
• Metabolic Disorders
• Neuroinflammation

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Georgia Tsaousi | Conditions: Brain Tumor, Metabolic Disturbance | Phase 4 | Status: COMPLETED